ReviewJournal of pathogens2017

Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment.

Sin-Yeang Teow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.